Holding(s) in Company

RNS Number : 6103B

Dechra Pharmaceuticals PLC

21 September 2018

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Dechra Pharmaceuticals PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligation
Name			Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios
City and country of registered office (if applicable)			Edinburgh, Scotland
4. Full name of shareholder(s) (if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi:			20/09/2018
6. Date on which issuer notified (DD/MM/YYYY):			21/09/2018
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached	8.23	0.03		8.26	102,329,635
Position of previous notification (if applicable)	8.39	0.02		8.41

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rightsix					% of voting rights
		Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)			Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009633180		N/A		8,422,492			N/A		8.23
SUBTOTAL 8. A		8,422,492					8.23
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument		Expiration datex	Exercise/ Conversion Periodxi			Number of voting rights that may be acquired if the instrument is Exercised/converted.			% of voting rights
Rights to recall lent shares						25,760			0.03
			SUBTOTAL 8. B 1			25,760			0.03
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration datex		Exercise/ Conversion Period xi		Physical or cash settlementxii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)				X
Namexv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Standard Life Aberdeen plc
Standard Life Investments (Holdings) Limited
Standard Life Investments Limited
Standard Life Aberdeen plc
Aberdeen Asset Management PLC
Aberdeen Asset Investment Group Limited
Aberdeen Asset Investments Limited
Standard Life Aberdeen plc
Aberdeen Asset Management PLC
Aberdeen Asset Managers Limited
Standard Life Aberdeen plc
Standard Life Investments (Holdings) Limited
Standard Life Wealth Limited
Standard Life Aberdeen plc
Standard Life Investments (Holdings) Limited
Ignis Asset Management Limited
Ignis Investment Services Limited
10. In case of proxy voting, please identify:
Name of the proxy holder		N/A
The number and % of voting rights held		N/A
The date until which the voting rights will be held		N/A
11. Additional informationxvi
In reference to section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager. This disclosure is to reflect the fact that the voting rights effectively held indirectly by the underlying intermediate holding company Standard Life Investments (Holdings) Limited ("SLIHL") decreased below the 5% notifiable threshold due to trading on 20 September 2018. SLIHL now effectively holds the delegated voting rights to 4.92% of the shares in Dechra Pharmaceuticals PLC. Prior to this crossing, SLIHL effectively held 5.06% of the delegated voting rights.

Place of completion	Edinburgh, United Kingdom
Date of completion	21/09/2018

Annex: Notification of major holdings (to be filed with the FCA only)
A: Identity of the person subject to the notification obligation
Full name (including legal form for legal entities)		Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios
Contact address (registered office for legal entities)		1 George Street Edinburgh EH2 2LL
E-Mail
Phone number / Fax number
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name		Vikas Sharma
Contact address		1 George Street Edinburgh EH2 2LL
E-Mail		Vikas. [e-mail]
Phone number / Fax number		[phone]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information

Please send the completed form together with this annex to the FCA at the following email address: [e-mail]. Please send in Microsoft Word format if possible. 

 

END

 

 

HOLDMGZLKMFGRZM